Viemed Healthcare, Inc. (NASDAQ:VMD) Director Randy E. Dobbs Sells 36,261 Shares

Viemed Healthcare, Inc. (NASDAQ:VMD) Director Randy E. Dobbs sold 36,261 shares of the stock in a transaction that occurred on Wednesday, November 13th. The stock was sold at an average price of $9.28, for a total value of $336,502.08. Following the transaction, the director now directly owns 107,706 shares of the company’s stock, valued at approximately $999,511.68. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website.

Viemed Healthcare Stock Performance

VMD opened at $9.15 on Thursday. Viemed Healthcare, Inc. has a 1-year low of $6.21 and a 1-year high of $10.44. The stock has a market cap of $356.30 million, a P/E ratio of 33.89 and a beta of 1.43. The stock’s 50 day simple moving average is $8.31 and its 200 day simple moving average is $7.53. The company has a debt-to-equity ratio of 0.03, a current ratio of 1.31 and a quick ratio of 1.19.

Viemed Healthcare (NASDAQ:VMD) last released its earnings results on Wednesday, November 6th. The company reported $0.10 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.08 by $0.02. Viemed Healthcare had a net margin of 4.87% and a return on equity of 8.72%. The company had revenue of $58.00 million for the quarter.

Hedge Funds Weigh In On Viemed Healthcare

Institutional investors have recently added to or reduced their stakes in the business. BBR Partners LLC purchased a new position in shares of Viemed Healthcare in the 3rd quarter worth $110,000. Millrace Asset Group Inc. raised its holdings in Viemed Healthcare by 13.3% in the third quarter. Millrace Asset Group Inc. now owns 231,322 shares of the company’s stock valued at $1,696,000 after buying an additional 27,084 shares during the period. Thrivent Financial for Lutherans lifted its position in Viemed Healthcare by 0.6% during the third quarter. Thrivent Financial for Lutherans now owns 3,425,693 shares of the company’s stock valued at $25,110,000 after buying an additional 21,047 shares in the last quarter. Bard Associates Inc. lifted its position in Viemed Healthcare by 1.1% during the third quarter. Bard Associates Inc. now owns 345,052 shares of the company’s stock valued at $2,529,000 after buying an additional 3,762 shares in the last quarter. Finally, Oppenheimer Asset Management Inc. increased its position in shares of Viemed Healthcare by 5.6% in the third quarter. Oppenheimer Asset Management Inc. now owns 30,222 shares of the company’s stock worth $222,000 after acquiring an additional 1,601 shares in the last quarter. 74.24% of the stock is currently owned by institutional investors and hedge funds.

Viemed Healthcare Company Profile

Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.